Published in J Physiol on June 15, 2012
Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: data from two randomised trials. Eur Respir J (2015) 2.07
Obstructive sleep apnea during REM sleep and hypertension. results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med (2014) 1.68
CrossTalk opposing view: Most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation. J Physiol (2012) 0.83
Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention. Chest (2015) 0.80
Obstructive sleep apnea during rapid eye movement sleep: clinical relevance and therapeutic implications. Curr Opin Pulm Med (2016) 0.75
The carotid body in cardiovascular disease: more chicken and egg than horse and cart? J Physiol (2012) 0.75
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (2005) 17.31
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet (2004) 6.37
Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med (1993) 5.85
Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation (2010) 5.70
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet (2010) 3.53
Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med (2007) 3.07
Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax (1992) 2.21
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12
Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol (2010) 2.12
Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension (2006) 1.97
Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol (1985) (2006) 1.96
Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol (1985) (1993) 1.89
CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J (2008) 1.85
Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol (2004) 1.73
Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med (2011) 1.71
Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system. J Hypertens (1997) 1.62
Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res (2007) 1.56
QRISK or Framingham for predicting cardiovascular risk? BMJ (2009) 1.45
The role of cardiac autonomic function in hypertension and cardiovascular disease. Curr Hypertens Rep (2009) 1.44
Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans. J Auton Nerv Syst (1993) 1.31
Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med (2007) 1.27
14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J (2010) 1.23
Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest (2001) 1.21
Immediate effects of arousal from sleep on cardiac autonomic outflow in the absence of breathing in dogs. J Appl Physiol (1985) (1995) 1.18
Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans. J Physiol (2009) 1.03
Heart rate: a forgotten link in coronary artery disease? Nat Rev Cardiol (2011) 1.00
Intermittent hypoxia-mediated plasticity of acute O2 sensing requires altered red-ox regulation by HIF-1 and HIF-2. Ann N Y Acad Sci (2009) 0.92
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet (2002) 4.86
Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med (2008) 4.38
Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax (2007) 3.07
Is continuous positive airway pressure necessarily an everyday therapy in patients with obstructive sleep apnoea? Eur Respir J (2014) 2.67
Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol (2010) 2.12
Is a raised bicarbonate, without hypercapnia, part of the physiologic spectrum of obesity-related hypoventilation? Chest (2015) 2.07
Obesity hypoventilation syndrome: does the current definition need revisiting? Thorax (2013) 2.05
A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med (2003) 1.72
Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med (2011) 1.71
Effects of obstructive sleep apnoea on heart rhythm. Eur Respir J (2012) 1.71
The effects of simulated obstructive apnea and hypopnea on arrhythmic potential in healthy subjects. Eur J Appl Physiol (2012) 1.54
High prevalence of sleep disordered breathing in patients with diabetic macular edema. Retina (2012) 1.49
Predictors of long-term compliance with continuous positive airway pressure. Thorax (2010) 1.43
A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev (2009) 1.20
The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: A randomised controlled trial. Sleep Med (2009) 1.08
Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study. J Sleep Res (2006) 1.03
Systemic hypertension and obstructive sleep apnoea. Sleep Med Rev (2002) 0.98
The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trial. Eur Heart J (2012) 0.94
Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. J Sleep Res (2009) 0.90
Pharmacological approaches to the treatment of obstructive sleep apnoea. Expert Opin Investig Drugs (2009) 0.89
The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial. Thorax (2013) 0.86
An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome. Int J Technol Assess Health Care (2009) 0.84
Snoring and severity of symptomatic and asymptomatic carotid stenosis: a population-based study. Sleep (2012) 0.84
Obstructive sleep apnea in patients with abdominal aortic aneurysms: highly prevalent and associated with aneurysm expansion. Am J Respir Crit Care Med (2010) 0.84
Exhaled nitric oxide as a screening tool for asthma in school children. Respir Med (2006) 0.82
Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions. Expert Opin Investig Drugs (2011) 0.82
Effect of simulated obstructive hypopnea and apnea on thoracic aortic wall transmural pressures. J Appl Physiol (1985) (2013) 0.82
Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial. Respiration (2008) 0.81
Obstructive sleep apnoea in adults. BMJ (2009) 0.80
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea. Cerebrovasc Dis (2013) 0.80
The impact of obstructive sleep apnea on aortic disease in Marfan's syndrome. Respiration (2012) 0.80
Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea: a randomized controlled trial. Sleep Med (2013) 0.79
Augmentation index and central aortic blood pressure in patients with abdominal aortic aneurysms. J Hypertens (2010) 0.79
The role of the nose in the pathogenesis of obstructive sleep apnea. Curr Opin Otolaryngol Head Neck Surg (2009) 0.78
Visual improvement following continuous positive airway pressure therapy in diabetic subjects with clinically significant macular oedema and obstructive sleep apnoea: proof of principle study. Respiration (2011) 0.77
Road ahead to respiratory health: experts chart future research directions. Respirology (2009) 0.76
OSA and hypertension: do we know all the answers? Chest (2013) 0.76
Sleep study predictors of prevalent cardiovascular disease. Am J Respir Crit Care Med (2009) 0.75
Blood Pressure Variability in Obstructive Sleep Apnoea: Data from 4 Randomised Controlled CPAP Withdrawal Trials. Respiration (2017) 0.75
Reducing the cost of treating obstructive sleep apnea: good news for patients. Am J Respir Crit Care Med (2004) 0.75